B1: Medication safety through digital innovation

Thursday 19th September 2019

Part A: Use of Information Technology and cloud medication history to improved medication safety

Health IT has been used extensively in improving medication safety in Taiwan. The availability of cloud medication and medical records in recent years extend the value of use of IT in improving medication safety. Our experiences provide lessons learned during the process of implementation and provide guidance for future integration and development.

After this session, participants will be able to:

  1. See how IT is helpful in improving medication safety.

  2. Understand how cloud medication history is used in improving medication safety in Taiwan.

  3. Appreciate the issues of continuing to improve medication safety using IT in Taiwan.

Francis SekKwong Poon, Chief, Section of Clinical Informatics, Patient quality department, Taichung Veterans General Hospital; Taiwan

Part B: Using a population-wide healthcare database to capture drug-related serious adverse events.

The Clinical Data Analysis and Reporting System (CDARS) is an electronic health records system of the Hong Kong Hospital Authority. Serious events, such as deaths, strokes and heart attacks, are captured with good accuracy. In this talk, using CDARS to identify drug-related serious adverse events will be illustrated with several examples, the most recent of which was the effect of the withdrawal of five generic products containing valsartan suspected to be contaminated by N-nitrosodimethylamine. 30,000 patients were affected. We monitored the stroke rate in Hong Kong before and after the sudden recall.

After this session, participants will be able to:

  1. Understand how a population-wide electronic healthcare record system can be used to monitor rare drug-related adverse events.

  2. Understand the impact of a sudden withdrawal and recall of a widely-used medicinal product.

  3. Understand how to manage safely a crisis arising from drug safety.

Bernard Cheung, Professor in Cardiovascular Therapeutics, Sun Chieh Yeh Heart Foundation; Hong Kong